July 2013 The Supreme Court and DNA Patents


The Supreme Court and DNA Patents: A Myriad of Ramifications

Monday, July 1, 2013

Wilson Sonsini Goodrich & Rosati

650 Page Mill Road
Palo Alto, CA 94304

Panel Discussion 3:30-5:30 PM
Networking Reception 5:30-7:00 PM

In Association for Molecular Pathology v Myriad Genetics,
Inc., a unanimous Supreme Court held that isolated
naturally-occurring human DNA is not patentable subject matter, but
synthetic c-DNA is patent eligible. On July 1, The Berkeley Center for
Law & Technology (BCLT) and the law firm of Wilson Sonsini
Goodrich and Rosati will co-host a panel on the meaning and impact of
the Court’s decision.

Panelists include:

Benjamin Jackson, Senior Director of Legal Affairs at Myriad Genetics

Nathan Kelley, Deputy Solicitor at US Patent and Trademark Office

Vern Norviel, Wilson Sonsini Goodrich & Rosati

Michael Shuster
, Fenwick & West LLP

Judge Alex Kozinski, United States Court of Appeals for the Ninth Circuit

The panel will be held at Wilson Sonsini Goodrich &
Rosati’s Palo Alto office at 3:30 PM and will be followed by a
networking reception. Final logistics, including the exact location,
will be sent before the event.

There is no charge to
attend, but pre-registration is
Please contact Associate Director Louise Lee at llee@law.berkeley.edu to register.

2.0 hours of CLE credit will be available for this panel.